Organon (OGN) Change in Taxes (2020 - 2026)
Organon (OGN) recorded quarterly Change in Taxes of -$4.0 million in Q1 2026, up 87.1% quarter-over-quarter from -$31.0 million in Q4 2025, and down 110.53% on a YoY basis from $38.0 million in Q1 2025.
Organon (OGN) Change in Taxes (2020 - 2026) Analysis & Trends
Organon's Change in Taxes history runs 7 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- In Q1 2026, Change in Taxes fell 110.53% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$103.0 million (down 390.48% YoY), while the FY2025 annual figure was -$61.0 million, up 6.15% from the prior year.
- Change in Taxes was -$4.0 million for Q1 2026 at Organon, up from -$31.0 million in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $38.0 million in Q1 2025 to a low of -$89.0 million in Q4 2024.
- Historically, Change in Taxes has averaged -$6.3 million across 5 years, with a median of $2.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Change in Taxes sank 1550.0% in 2023, then jumped 1000.0% in 2024.
- A 5-year view of Change in Taxes shows it stood at -$38.0 million in 2022, then jumped by 197.37% to $37.0 million in 2023, then slumped by 340.54% to -$89.0 million in 2024, then surged by 65.17% to -$31.0 million in 2025, then jumped by 87.1% to -$4.0 million in 2026.
- The last three Change in Taxes figures came in at -$4.0 million (Q1 2026), -$31.0 million (Q4 2025), and -$76.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | 411.19 Mn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | -81.00 Mn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | - |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 71.00 Mn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | -29.00 Mn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 187.00 Mn |
| 10 | Organon | 3.50 Bn | 2.39 Bn | 783.00 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | -31.00 Mn |
| Dec 31, 2025 | -31.00 Mn |
| Sep 30, 2025 | -76.00 Mn |
| Sep 30, 2025 | -76.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Dec 31, 2024 | -89.00 Mn |
| Dec 31, 2024 | -89.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Dec 31, 2023 | 37.00 Mn |
| Dec 31, 2023 | 37.00 Mn |